Soluble HLA-G expression levels and HLA-G/irinotecan association in metastatic colorectal cancer treated with irinotecan-based strategy

We here explore the soluble Human Leukocyte Antigen-G (sHLA-G) expression level as clinical biomarker in metastatic colorectal cancer (mCRC). To this aim the sHLA-G protein was measured in plasma samples of 40 patients with mCRC treated with the FOLFIRI (irinotecan (CPT-11) plus 5-fluorouracil (5-FU...

Descripción completa

Detalles Bibliográficos
Autores principales: Scarabel, Lucia, Garziera, Marica, Fortuna, Sara, Asaro, Fioretta, Toffoli, Giuseppe, Geremia, Silvano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7260212/
https://www.ncbi.nlm.nih.gov/pubmed/32471996
http://dx.doi.org/10.1038/s41598-020-65424-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7260212/
https://www.ncbi.nlm.nih.gov/pubmed/32471996
http://dx.doi.org/10.1038/s41598-020-65424-z

Ejemplares similares